---
document_datetime: 2024-09-11 13:07:04
document_pages: 8
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ibandronic-acid-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: ibandronic-acid-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 5.1538361
conversion_datetime: 2025-12-27 13:48:48.330249
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Ibandronic acid Accord

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0029              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 10/09/2024                          |                                             | SmPC and PL                      |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IA/0028   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                            | 13/07/2023   | n/a        |                 |        |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|--------|
| IA/0027   | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                         | 19/01/2023   | n/a        |                 |        |
| IB/0026   | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation                                                                                                                                              | 05/01/2023   | 05/01/2024 | SmPC and PL     |        |
| IB/0025   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                   | 12/04/2022   | 20/12/2022 | SmPC            |        |
| IA/0024   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                               | 22/12/2021   | 20/12/2022 | Annex II and PL |        |
| IB/0023/G | This was an application for a group of variations. B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change manufacturing process | 29/09/2021   | n/a        |                 | in the |

<div style=\"page-break-after: always\"></div>

|             | Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products   |            |            |                 | B.II.b.1.a -   |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|----------------|
| IB/0022     | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                        | 19/10/2020 | n/a        |                 |                |
| IAIN/0021   | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                      | 08/07/2020 | 24/06/2021 | Annex II and PL |                |
| IAIN/0020/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging                                                                                                                                                                                                                         | 16/12/2019 | n/a        |                 | site           |

<div style=\"page-break-after: always\"></div>

| IA/0019     | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                   | 28/08/2019   | n/a        |                                  |                                                                                                                                                                             |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0017     | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                         | 18/07/2019   | n/a        |                                  |                                                                                                                                                                             |
| T/0016      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                          | 01/02/2019   | 20/02/2019 | SmPC, Labelling and PL           |                                                                                                                                                                             |
| IAIN/0015/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 12/10/2018   | 20/02/2019 | Annex II and PL                  |                                                                                                                                                                             |
| IA/0014     | B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                            | 27/07/2018   | n/a        |                                  |                                                                                                                                                                             |
| R/0013      | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                      | 20/07/2017   | 18/09/2017 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Ibandronic acid Accord in the approved indication remains |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |            |                       | favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity.   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|------------------------------------------------------------------------------------------------------------|
| IA/0012   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 17/01/2017 | 18/09/2017 | Annex II and PL       |                                                                                                            |
| IB/0011/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by | 20/06/2016 | 12/08/2016 | SmPC, Annex II and PL |                                                                                                            |
| IA/0010/G | This was an application for a group of variations. B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement or addition) B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State                                                                                                                           | 18/03/2016 | n/a        |                       |                                                                                                            |

<div style=\"page-break-after: always\"></div>

| IB/0009   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   | 11/09/2015   | 12/08/2016   | SmPC, Labelling and PL           |                     |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|---------------------|
| X/0006    | To add a new strength/potency and a new pharmaceutical form 3 mg solution for injection. Annex I_2.(c) Change or addition of a new strength/potency Annex I_2.(d) Change or addition of a new                                                                  | 22/01/2015   | 23/03/2015   | SmPC, Annex II, Labelling and PL | pharmaceutical form |
| IB/0008   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   | 04/07/2014   | 23/03/2015   | SmPC and PL                      |                     |
| IB/0007   | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                            | 15/04/2014   | n/a          |                                  |                     |
| IA/0005/G | This was an application for a group of variations. B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new                                                                       | 10/03/2014   | n/a          |                                  |                     |

<div style=\"page-break-after: always\"></div>

|           | specification parameter to the specification with its corresponding test method B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State B.I.b.2.c - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure for a reagent, which does not have a significant effect on the overall quality of the AS   |            |            |                       |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|
| IA/0004   | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 12/11/2013 | n/a        |                       |
| IAIN/0003 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 30/08/2013 | n/a        |                       |
| IB/0002   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                                                                 | 02/05/2013 | 08/01/2014 | SmPC, Annex II and PL |

<div style=\"page-break-after: always\"></div>

| IAIN/0001/G   | was an application for a group of variations.   | 03/01/2013   | 08/01/2014   | Annex II and PL   | This B.II.b.2.a - Change to batch and quality control testing of or addition of a site where batch takes place B.II.b.2.b.1 - Change to batch and quality control testing of batch control/testing   |
|---------------|-------------------------------------------------|--------------|--------------|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|